Announcements Trials
Browse Landscape

Status

Recruiting 7Completed 3Active not recruiting 2Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 13Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 5Prostatic Neoplasms 4Neoplasm Metastasis 3Melanoma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Multiple Myeloma 2Lung Neoplasms 2Liver Neoplasms 2Glioblastoma 2Fibrosis 2Colorectal Neoplasms 2Cachexia 2Vascular Malformations 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Renal Insufficiency, Chronic 1Recurrence 1Pneumonia 1Ovarian Neoplasms 1Ovarian Cysts 1Osteosarcoma 1Obesity 1

Interventions

Fluorouracil 17Cisplatin 17pembrolizumab 12Radiotherapy 11Oxaliplatin 10Irinotecan 9Paclitaxel 6Leucovorin 6Docetaxel 6Carboplatin 6Capecitabine 6Neoadjuvant Therapy 5Trastuzumab 4Panitumumab 4Gefitinib 4Esophagectomy 4Cyclophosphamide 4Cetuximab 4Surgical Procedures, Operative 3Celecoxib 3tegafur-gimeracil-oteracil 2spartalizumab 2sodium glycididazole 2niraparib 2fludarabine 2S 1 (combination) 2Plicamycin 2Pemetrexed 2Lapatinib 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Esophageal Neoplasms × Blood Specimen Collection × Clear all
NCT03108885 2024-03-22

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

Mayo Clinic

Terminated
11 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡